2025-10-08 2025-10-08 , online online, 490 € plus tax Dr. Olaf Pirk https://www.forum-institut.com/seminar/25122048-e-learning-amnog-briefly-and-concisely/referenten/25/25_12/25122048-e-learning-amnog-briefly-and-concisely_pirk-olaf.jpg e-Learning: AMNOG briefly and concisely

e-Learning in 5 modules: concept, data requirements and the AMNOG process up to the price negotiation

Topics
  • Benefit Assessment: HTA in Europe, AMNOG in Germany
  • Benefit Assessment according to § 35a SGB V - a Quick Overview
  • The Structure of the Benefit Dossier (AMNOG Value Dossier)
  • Data Requirements for the Benefit Dossier
  • The AMNOG Process and Interactions with Decision-Makers


Who should attend
This e-Learning is designed for anyone seeking an initial insight into the AMNOG procedure. It covers both the data and the process level. No prior HTA/AMNOG knowledge is required; however, a basic understanding of the German healthcare system is helpful.
Aims and objectives
Are you expected to contribute data for the German benefit dossier or become involved in the German AMNOG process?
This e-Learning provides you with a solid understanding of dossier preparation and the overall procedure - from the first interaction with the G-BA to the reimbursement price negotiation.

After completing this e-Learning, you will understand the procedural steps and be familiar with the fundamental principles of benefit dossier preparation, including its practical hurdles and challenges.

The e-Learning was fully updated in October 2025 and made available in English with AI-assisted translation.
Your benefit

Through this e-Learning, you will:

  • Gain a concise understanding of the entire AMNOG process
  • Learn how all stakeholders operate
  • Understand the structure and essential content of the benefit dossier

25122048 Seminar e-Learning: AMNOG briefly and concisely

e-Learning: AMNOG briefly and concisely

Benefits
  • Quickly learn the essentials of the AMNOG process and the benefit dossier
  • Understand the interrelations between data requirements, G-BA assessment and price negotiation

Webcode 25122048

Book now

JETZT Buchen

Speaker


Everything at a glance

Appointment

anytime

anytime

Period

Venue

online

online

Fee
Your contact

Dr. Henriette Wolf-Klein
Head of Department

+49 6221 500-680
h.wolf-klein@forum-institut.de

Details

e-Learning in 5 modules: concept, data requirements and the AMNOG process up to the price negotiation

Topics

  • Benefit Assessment: HTA in Europe, AMNOG in Germany
  • Benefit Assessment according to § 35a SGB V - a Quick Overview
  • The Structure of the Benefit Dossier (AMNOG Value Dossier)
  • Data Requirements for the Benefit Dossier
  • The AMNOG Process and Interactions with Decision-Makers


Who should attend
This e-Learning is designed for anyone seeking an initial insight into the AMNOG procedure. It covers both the data and the process level. No prior HTA/AMNOG knowledge is required; however, a basic understanding of the German healthcare system is helpful.

Aims and objectives

Are you expected to contribute data for the German benefit dossier or become involved in the German AMNOG process?
This e-Learning provides you with a solid understanding of dossier preparation and the overall procedure - from the first interaction with the G-BA to the reimbursement price negotiation.

After completing this e-Learning, you will understand the procedural steps and be familiar with the fundamental principles of benefit dossier preparation, including its practical hurdles and challenges.

The e-Learning was fully updated in October 2025 and made available in English with AI-assisted translation.

Your benefit

Through this e-Learning, you will:

  • Gain a concise understanding of the entire AMNOG process
  • Learn how all stakeholders operate
  • Understand the structure and essential content of the benefit dossier

Program

Module 1: Benefit assessment - do we even need it?
  • Health Technology Assessments (HTA) as a basis for evaluation
  • AMNOG and reimbursement price: Efficiency and cost reduction in the German healthcare system

Module 2: Benefit assessment according to § 35a SGB V
  • AMNOG process at a glance
  • Appropriate comparative treatment as an ideal comparator
  • Patient relevance as endpoints

Module 3: The structure of the dossier
  • Structure and content of the modules 1 - 5

Module 4: Data for the dossier
  • Rules of procedure
  • Data sources for modules 2 and 3
  • Module 4 - Data from pivotal and other studies
  • From development plan to market access

Module 5: The AMNOG process and the meeting with decision-makers
  • The consultation at the G-BA's administrative office
  • Hearing
  • Price negotiation with the National Association of Statutory Health Insurance Funds (GKV-SV)
  • Arbitration board

Trailer

e-Learning: AMNOG briefly and concisely

Here you get a brief insight into the e-learning course AMNOG briefly and concisely.

Your benefit

Professional training – anytime and anywhere

This e-learning course gives you the opportunity to acquire professional know-how on AMNOG whenever and wherever you wish.

The e-learning program consists of several didactically structured learning modules. These include expert videos, graphics and explanatory texts, podcast elements, and practical exercises. In this way, you will become familiar with the regulatory requirements and their practical implementation.
Each module concludes with a learning assessment. Once you have completed all modules and successfully passed the assessments, you will receive a qualifying certificate, which you can conveniently print out yourself.

How does it work exactly? 1. You book the e-learning course on our website.
2. You will receive an email with your login details for our customer portal, from which you will be directed to the learning platform.
3. You log in to our learning platform using these credentials.
4. You start your learning modules individually. In addition, you will receive an informative accompanying presentation.
  • 5. You complete each module with a learning assessment.
  • 6. After successfully completing the course, you will receive a certificate as proof of achievement.

Try the DEMO version of our e-learning course free of charge and get an insight into our learning environment!

This distinguishes our events

of 5 stars of all ratings from 2024

of 5 stars on Trustpilot = good

Recommendations

Pharma Pricing under Pressure: U.S. Reforms and Potential Implications for the EU Industry

Explore how recent U.S. pharmaceutical pricing reforms may impact the European pharma sector. This online seminar provid...

08.12.2025 in
Details

Patient Involvement in HTA

This course offers a deep dive into patient involvement in HTA processes across Europe, with a focus on the UK and Germa...

19.03.2026 in
Details

Leveraging AI in Evidence Generation and Market Access

Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essent...

19.01.2026 in
Details

All about ATMP

Das Online-Seminar zu den Themen Entwicklung, Qualität, CMC, Zulassung und Market Access für ATMPs.

23. - 24.03.2026 in
Details
Strategic Market Access in Europe: From HTA to Pricing Negotiations

This online seminar provides a comprehensive introduction to drug market access and pricing strategies in five key Europ...

09. - 10.12.2025 in
Details

Go forward

e-Learning - Click and learn

We provide flexible education and training with high-quality e-Learning programmes for several topics.

Details
e-Learning
DEMO-Account e-Learning

Try out our e-Learning programmes free of charge and without any obligation.

Details
DEMO-Account e-Learning
We guarantee the highest quality

We are now officially certified to ISO 9001 and ISO 21001 standard.

Details
We guarantee the highest quality